Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therap (NQ: CAPR )

4.290 USD +0.260 (+6.45%)
Official Closing Price Updated: 4:43 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 604,100
Open 4.050
Bid (Size) 4.200 (1)
Ask (Size) 4.290 (53)
Prev. Close 4.030
Today's Range 3.910 - 4.370
52wk Range 0.8800 - 12.32
Shares Outstanding 29,110,053
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Capricor Therapeutics Commences Dosing Patients in Phase 2 Trial of CAP-1002 in Patients with Severe COVID-19
From GlobeNewswire News Releases
Capricor Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases

Performance

YTD
+248.78%
+248.78%
1 Month
+6.19%
+6.19%
3 Month
-18.44%
-18.44%
6 Month
-7.54%
-7.54%
1 Year
+176.77%
+176.77%

More News

Read More
Capricor Therapeutics Announces Positive Preclinical Data for Multivalent Exosome-mRNA Vaccine For COVID-19
From GlobeNewswire News Releases
Capricor Therapeutics to Present Third Quarter 2020 Financial Results and Recent Corporate Update on November 12
From GlobeNewswire News Releases
Capricor Therapeutics to Present Results from the HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at the International World Muscle Society Virtual Congress 2020
From GlobeNewswire News Releases
Capricor Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
From GlobeNewswire News Releases
12 Healthcare Stocks Moving In Thursday's After-Market Session
Tags THC Health Care GH
From Benzinga
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Tags Benzinga Movers CHEK
From Benzinga
First Week of CAPR November 20th Options Trading
Tags Stocks
From Market News Video
Doubling Down On China's COVID-19 Bio-Tech Disrupters
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.